Maryville, IL, United States of America

Albert M Crider

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Southern Illinois University. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Albert M Crider. Retrieved from https://idiyas.com/inventor/albert-m-crider

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Albert M Crider

Introduction

Albert M Crider is a notable inventor based in Maryville, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of two patents to his name, Crider's work focuses on innovative solutions that address specific medical needs.

Latest Patents

Crider's latest patents include the development of 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles. These compounds are recognized as somatostatin receptor type 4 agonists, which have potential therapeutic applications. The disclosures detail the unique properties and uses of these compounds, highlighting their significance in medical research.

Career Highlights

Crider is affiliated with Southern Illinois University, where he contributes to research and innovation in his field. His academic background and professional experience have positioned him as a key figure in the development of new pharmaceutical compounds.

Collaborations

Some of Crider's notable coworkers include Kenneth A Witt and William L Neumann. Their collaborative efforts have likely enhanced the research and development processes within their projects.

Conclusion

Albert M Crider's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…